GSK3B and breast carcinoma: By downregulating the protein expression of p-Akt, p-GSK3B, and β-catenin, ACP blocked the Akt/GSK-3β signaling pathway in breast cancer cells, which in turn had anti-proliferation, anti-migration, and anti-invasion effects [5].